REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/18/2025
Back to search
Official data from USPTO
NT NOVOTECH THE ASIA PACIFIC CRO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
08/19/2025
Trademark type
Combined
Nice classes
42
Filing date
11/22/2019
Registration date
08/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/18/2020
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
AU
Examiner
BLAZICH,JOAN MICHELE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "NT NOVOTECH" above "THE ASIA PACIFIC CRO", all in stylized font.
Holders and representatives
Holders
Novotech (Australia) Pty Ltd
Representatives
Eleanor M. Yost Carlton Fields, PA
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Conducting clinical trials for others; conducting and managing clinical trials in the nature of conducting clinical trials for others in the field of pharmaceuticalsbiotechnology and other related industries; conducting clinical trials for others scientific research; providing medical and scientific research information about the results of clinical trialsincluding clinical trials for pharmaceuticals and biotechnology; scientific research; scientific research for medical purposes in the field of pharmaceuticalsbiotechnologyrelated industries; preparation of statisticsscientific analysis in the field of clinical trial results for scientific research; preparation of biostatisticsscientific analysis in the field of clinical trial results for scientific research in the fields of pharmaceuticalsbiotechnology and other related industries; provision of medical and scientific research information and data relating to medical and scientific research for pharmaceuticalsbiotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research servicesmedical monitoring services for research in the fields of pharmaceuticalsbiotechnology and other related industries; quality auditsinspection for quality control purposes and quality control for otherstechnology supervision and technical verification of clinical trial designs and clinical trial data; preparation of reports and applications to regulators relating to aspects of clinical trialsproviding medical research and scientific information and data in the field of clinical trials; provision and exchange of information and data exchange between scientistsmanufacturers and health authorities relating to pharmaceutical and biotechnology quality standardsproviding a website featuring technology enabling authorized users to generatemanageexchange medical and scientific informationdata and documents; technical writing of clinical report forms which are required by clinical trial drug protocols
Publications
History of USPTO decisions and trademark events.
28 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/26/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/07/2020
FIMP
FINAL DISPOSITION PROCESSED
12/07/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/18/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
08/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/02/2020
PUBO
PUBLISHED FOR OPPOSITION
06/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/13/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/29/2020
ALIE
ASSIGNED TO LIE
04/28/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/22/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/22/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/22/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/22/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/22/2020
RFNT
REFUSAL PROCESSED BY IB
04/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/20/2020
RFRR
REFUSAL PROCESSED BY MPU
03/19/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/03/2020
CNRT
NON-FINAL ACTION WRITTEN
03/02/2020
DOCK
ASSIGNED TO EXAMINER
02/26/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2020
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
12/19/2019
Continuous trademark protection
Get notified about every new filing that threatens NT NOVOTECH THE ASIA PACIFIC CRO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.